GENinCode (STU:9PL) Accounts Payable: €1.46 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is GENinCode Accounts Payable?

GENinCode STU:9PL Accounts Payable is €1.46 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

GENinCode's Accounts Payable for the quarter that ended in Dec. 2025 was €1.46 Mil.

GENinCode's quarterly Accounts Payable increased from Dec. 2024 (€0.74 Mil) to Jun. 2025 (€1.60 Mil) but then declined from Jun. 2025 (€1.60 Mil) to Dec. 2025 (€1.46 Mil).

GENinCode's annual Accounts Payable declined from Dec. 2023 (€1.39 Mil) to Dec. 2024 (€0.74 Mil) but then increased from Dec. 2024 (€0.74 Mil) to Dec. 2025 (€1.46 Mil).

GENinCode Accounts Payable Historical Data

* Premium members only.

The historical data trend for GENinCode's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GENinCode Accounts Payable Chart

GENinCode Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 0.41 1.63 1.39 0.74 1.46

GENinCode Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.39 1.63 0.74 1.60 1.46

GENinCode Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of €1.46 Mil mean?
GENinCode (STU:9PL) has a Accounts Payable of €1.46 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on GENinCode and its competitors.
Is GENinCode's Accounts Payable too high?
GENinCode's current Accounts Payable is €1.46 Mil.
How does GENinCode's Accounts Payable compare to TMO and DHR?
GENinCode's Accounts Payable of €1.46 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Medical Diagnostics & Research company?
A good Accounts Payable depends on the Medical Diagnostics & Research industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on GENinCode and its competitors. GENinCode's current Accounts Payable is €1.46 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GENinCode stock overvalued right now?
GENinCode (STU:9PL) has a current Accounts Payable of €1.46 Mil. The current Accounts Payable is €1.46 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For GENinCode (STU:9PL), the current Accounts Payable is €1.46 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GENinCode Business Description

Other Exchanges GENI:UK
Address Oxford Science Park, John Eccles House, Robert Robertson Avenue, Oxford, GBR, OX4 4GP
GENinCode PLC principal activity is the development and commercialisation of clinical genetic tests, to provide predictive analysis of risk to a patient's health based on their genes. The company has one operating segment. The company has presence in Spain, UK, United States, Italy, Germany, and Rest of World. The company generates majority of revenue from Spain. Its commercial products are CE-Marked, with CARDIO inCode, THROMBO inCode, and LIPID inCode.